Tumor necrosis factor‐α mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism†

Journal of Cellular Biochemistry - Tập 83 Số 1 - Trang 70-83 - 2001
Wei Zou1, Imad Hakim1, Katharina Tschoep2, Stefan Endres2, Zvi Bar‐Shavit3
1The H. Hubert Humphrey Center for Experimental Medicine and Cancer Research, The Hebrew University Faculty of Medicine, Jerusalem 91120, Israel.
2Division of Clinical Pharmacology, Department of Medicine Ludwig-Maximilians-University, Munich 80336, Germany
3The H Hubert Humphrey Center for Experimental Medicine and Cancer Research, The Hebrew University Faculty of Medicine, P.O. Box 12272, Jerusalem 91120, Israel.

Tóm tắt

Abstract

Osteoblasts or bone marrow stromal cells are required as supporting cells for the in vitro differentiation of osteoclasts from their progenitor cells. Soluble receptor activator of nuclear factor‐κB ligand (RANKL) in the presence of macrophage colony‐stimulating factor (M‐CSF) is capable of replacing the supporting cells in promoting osteoclastogenesis. In the present study, using Balb/c‐derived cultures, osteoclast formation in both systems—osteoblast/bone‐marrow cell co‐cultures and in RANKL‐induced osteoclastogenesis—was inhibited by antibody to tumor necrosis factor‐α (TNF‐α), and was enhanced by the addition of this cytokine. TNF‐α itself promoted osteoclastogenesis in the presence of M‐CSF. However, even at high concentrations of TNF‐α the efficiency of this activity was much lower than the osteoclastogenic activity of RANKL. RANKL increased the level of TNF‐α mRNA and induced TNF‐α release from osteoclast progenitors. Furthermore, antibody to p55 TNF‐α receptors (TNF receptors‐1) (but not to p75 TNF‐α receptors (TNF receptors‐2) inhibited effectively RANKL‐ (and TNF‐α() induced osteoclastogenesis. Anti‐TNF receptors‐1 antibody failed to inhibit osteoclastogenesis in C57BL/6‐derived cultures. Taken together, our data support the hypothesis that in Balb/c, but not in C57BL/6 (strains known to differ in inflammatory responses and cytokine modulation), TNF‐α is an autocrine factor in osteoclasts, promoting their differentiation, and mediates, at least in part, RANKL's induction of osteoclastogenesis. © 2001 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1002/jcb.240550404

10.1172/JCI119679

10.1002/jbmr.5650071109

10.1038/36593

10.1007/BF00296773

Baron R, 1986, Kinetic and cytochemical identification of osteoclast precursors and their differentiation into multinucleated osteoclasts, Am J Pathol, 122, 363

10.1006/bbrc.1998.8993

10.1006/bbrc.1998.8783

10.1083/jcb.145.3.527

10.1902/jop.1978.49.8.406

Goldman R, 1979, Dual effect of normal and stimulated macrophages and their conditioned media on target cell proliferation, J Natl Cancer Inst, 63, 1009

10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q

10.1016/S8756-3282(99)00162-3

10.1084/jem.191.2.313

10.1210/endo.139.11.6433

10.1073/pnas.96.7.3540

10.1007/s002510050487

10.1210/en.137.8.2187

10.4049/jimmunol.163.1.434

Kahn AJ, 1982, The relationship of monocytic cells to the differentiation and resorption of bone, Prog Clin Biol Res, 110, 239

10.1016/S0165-2427(98)00086-5

10.1172/JCI117606

10.1084/jem.191.2.275

10.1038/16852

Kurihara N, 1998, Macrophage‐stimulating protein (MSP) and its receptor, RON, stimulate human osteoclast activity but not proliferation: effect of MSP distinct from that of hepatocyte growth factor, Exp Hematol, 26, 1080

10.1016/S0092-8674(00)81569-X

10.1172/JCI11176

10.1073/pnas.97.4.1566

10.1007/s004410051160

Maini RN, 1993, TNF‐α in rheumatoid arthritis and prospects of anti‐TNF therapy, Clin Exp Rheumatol, 11, S173

10.1056/NEJM199502023320506

10.1002/jcb.240560312

10.1016/S0002-9440(10)65266-2

10.1359/jbmr.1999.14.9.1478

10.1006/bbrc.1998.9788

10.1136/ard.43.3.370

10.1084/jem.191.2.303

10.1007/BF00315989

10.1210/endo.139.10.6331

10.1615/CritRevEukarGeneExpr.v8.i1.10

Sambrook J, 1989, Molecular cloning: a laboratory manual, 1

10.1046/j.1365-2249.1999.00762.x

10.1007/BF00299320

10.1016/S0092-8674(00)80209-3

10.1210/edrv-13-1-66

Suda T, 1996, Principles of bone biology, 87

10.1210/edrv.20.3.0367

10.1210/endo-123-5-2600

10.1006/bbrc.1999.0252

10.1074/jbc.273.42.27091

10.1007/BF00191885

10.1073/pnas.90.24.11924

10.1177/00220345990780100601

Thomson BM, 1987, Tumor necrosis factors‐α and ‐β induce osteoblastic cells to stimulate osteoclastic bone resorption, J Immunol, 138, 775, 10.4049/jimmunol.138.3.775

10.1006/bbrc.1998.8610

10.1210/endo-125-4-1805

10.1016/8756-3282(96)00076-2

10.1128/IAI.68.4.2034-2042.2000

10.1111/cge.1999.21.2.57

10.1006/bbrc.1998.9035

10.1074/jbc.272.40.25190

10.1073/pnas.95.7.3597

10.1074/jbc.M008198200

Zou W, 2000, TNF‐α mediates RANK Ligand stimulation of osteoclast differentiation by an autocrine mechanism, J Bone Miner Res, 15, S174